MTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury

Journal of Leukocyte Biology

Volumn 95, Issue 6, 2014, Pages 961-970

  Zhang, Yan ^a,b   Bi, Yujing ^c   Yang, Hui ^a,b   Chen, Xi ^a,b   Liu, Huanrong ^a,b   Lu, Yun ^a,b   Zhang, Zhengguo ^a,b   Liao, Jiongbo ^a,b   Yang, Shan ^a,b   Chu, Yiwei ^a,b   Yang, Ruifu ^c   Liu, Guangwei ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Autoimmune; Cell migration; Immune defense; Inflammation; Inflammatory cell infiltration

Indexed keywords

CD11B ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOLOGICAL HEPATIC INJURY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER INJURY; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL;

AUTOIMMUNE; CELL MIGRATION; IMMUNE DEFENSE; INFLAMMATION; INFLAMMATORY CELL INFILTRATION;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CELL MOVEMENT; IMMUNE TOLERANCE; LIVER DISEASES; MICE; MYELOID CELLS; NITRIC OXIDE; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84901715203     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0913473     Document Type: Article

References (50)

1. Chi, H. (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325-338.
2. Liu, G., Burns, S., Huang, G., Boyd, K., Proia, R. L., Flavell, R. A., Chi, H. (2009) The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769-777.
3. Bi, Y., Liu, G., Yang, R. (2011) mTOR regulates T-cell differentiation and activation in immunity and autoimmunity. Crit. Rev. Eukaryot. Gene Expr. 21, 313-322.
4. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., Powell, J. D. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844.
5. Zoncu, R., Efeyan, A., Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell. Biol. 12, 21-35.
6. Baker, A. K., Wang, R., Mackman, N., Luyendyk, J. P. (2009) Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expression. Mol. Immunol. 46, 2249-2255.
7. Thomson, A. W., Turnquist, H. R., Raimondi, G. (2009) Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9, 324-337.
8. Wullschleger, S., Loewith, R., Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484.
9. Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R., Sigal, N. H. (1990) Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144, 251-258.
10. Yang, H., Wang, X., Zhang, Y., Liu, H., Liao, J., Shao, K., Chu, Y., Liu, G. (2014) Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity. J. Cell. Physiol. 229, 17-26.
11. Chen, H., Zhang, L., Zhang, H., Xiao, Y., Shao, L., Li, H., Yin, H., Wang, R., Liu, G., Corley, D., Yang, Z., Zhao, Y. (2013) Disruption of TSC1/2 signaling complex reveals a checkpoint governing thymic CD4+CD25+Foxp3+ regulatory T-cell development in mice. FASEB J. 27, 3979-3990.
12. Sehgal, S. N. (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplant. Proc. 35, 7S-14S.
13. Delgoffe, G. M., Powell, J. D. (2009) mTOR: taking cues from the immune microenvironment. Immunology 127, 459-465.
14. Havla, J., Kumpfel, T., Hohlfeld, R. (2012) [2012: update on diagnosis and treatment of multiple sclerosis]. Dtsch. Med. Wochenschr. 137, 894-899.
15. Ray, P., Arora, M., Poe, S. L., Ray, A. (2012) Lung myeloid-derived suppressor cells and regulation of inflammation. Immunol. Res. 50, 153-158.
16. Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67, 10019-10026.
17. Ostrand-Rosenberg, S., Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499-4506.
18. Jayaraman, P., Parikh, F., Lopez-Rivera, E., Hailemichael, Y., Clark, A., Ma, G., Cannan, D., Ramacher, M., Kato, M., Overwijk, W. W., Chen, S. H., Umansky, V. Y., Sikora, A. G. (2010) Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J. Immunol. 188, 5365-5376.
19. Van Rompaey, N., Le Moine, A. (2010) Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation. Methods Mol. Biol. 677, 169-180.
20. Liu, G., Bi, Y., Shen, B., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Liao, J., Chen, X., Chu, Y. (2014) SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF1α-dependent glycolysis. Cancer Res. 74, 727-737.
21. Ma, J., Pan, P. Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., Shu-Hsia, C. (2011) Paired immunoglobin-like receptor B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 25, 385-395.
22. Jiang, J., Zhou, C., Xu, Q. (2003) Alleviating effects of si-ni-san, a traditional Chinese prescription, on experimental liver injury and its mechanisms. Biol. Pharm. Bull. 26, 1089-1094.
23. Schumann, J., Prockl, J., Kiemer, A. K., Vollmar, A. M., Bang, R., Tiegs, G. (2003) Silibinin protects mice from T cell-dependent liver injury. J. Hepatol. 39, 333-340.
24. Cripps, J. G., Wang, J., Maria, A., Blumenthal, I., Gorham, J. D. (2010) Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 52, 1350-1359.
25. Liu, G., Hu, X., Sun, B., Yang, T., Shi, J., Zhang, L., Zhao, Y. (2013) Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1. Blood 121, 519-529.
26. Wu, T., Sun, C., Chen, Z., Zhen, Y., Peng, J., Qi, Z., Yang, X., Zhao, Y. (2012) Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J. Immunol. 189, 4989-5000.
27. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., Mc-Caffrey, J. C., Gabrilovich, D. I. (2012) HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439-2453.
28. Liu, G., Bi, Y., Wang, R., Shen, B., Zhang, Y., Yang, H., Wang, X., Liu, H., Lu, Y., Han, F. (2013) Kinase AKT1 negatively controls neutrophil recruitment and function in mice. J. Immunol. 191, 2680-2690.
29. Bi, Y., Zhou, J., Yang, H., Wang, X., Zhang, X., Wang, Q., Wu, X., Han, Y., Song, Y., Tan, Y., Du, Z., Yang, H., Zhou, D., Cui, Y., Zhou, L., Yan, Y., Zhang, P., Guo, Z., Wang, X., Liu, G., Yang, R. (2014) IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-α-activated macrophage programming. J. Immunol. 192, 704-713.
30. Blomgran, R., Ernst, J. D. (2013) Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J. Immunol. 186, 7110-7119.
31. Sun, B., Hu, X., Liu, G., Ma, B., Xu, Y., Yang, T., Shi, J., Yang, F., Li, H., Zhang, L., Zhao, Y. (2014) Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. J. Immunol. 192, 1184-1195.
32. Liu, L., Cuthbertson, F. (2012) Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis. Case Report Med. 12, 134636-134643.
33. Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 15, 10019-10026.
34. Kodumudi, K. N., Weber, A., Sarnaik, A. A., Pilon-Thomas, S. (2011) Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma. J. Immunol. 189, 5147-5154.
35. Rosborough, B. R., Castellaneta, A., Natarajan, S., Thomson, A. W., Turnquist, H. R. (2013) Histone deacetylase inhibition facilitates GMCSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. J. Leukoc. Biol. 91, 701-709.
36. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Muller, M., Blander, J. M., Tacke, F., Trautwein, C. (2009) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464.
37. Mundy-Bosse, B. L., Lesinski, G. B., Jaime-Ramirez, A. C., Benninger, K., Khan, M., Kuppusamy, P., Guenterberg, K., Kondadasula, S. V., Chaudhury, A. R., La Perle, K. M., Kreiner, M., Young, G., Guttridge, D. C., Carson, W. E. (2013) Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res. 71, 5101-5110.
38. Van Mourik, I. D., Kelly, D. A. (2001) Immunosuppressive drugs in paediatric liver transplantation. Paediatr. Drugs 3, 43-60.
39. Barshes, N. R., Goodpastor, S. E., Goss, J. A. (2004) Pharmacologic immunosuppression. Front. Biosci. 9, 411-420.
40. Chen, S., Akbar, S. M., Abe, M., Hiasa, Y., Onji, M. (2011) Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin. Exp. Immunol. 166, 134-142.
41. Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Horl, W. H., Hengstschlager, M., Muller, M., Saemann, M. D. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577.
42. Mcinturff, A. M., Cody, M. J., Elliott, E. A., Glenn, J. W., Rowley, J. W., Rondina, M. T., Yost, C. C. (2012) Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxiainducible factor 1 α. Blood 120, 3118-3125.
43. Weichhart, T., Haidinger, M., Katholnig, K., Kopecky, C., Poglitsch, M., Lassnig, C., Rosner, M., Zlabinger, G. J., Hengstschlager, M., Muller, M., Horl, W. H., Saemann, M. D. (2011) Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood 117, 4273-4283.
44. Schmitz, F., Heit, A., Dreher, S., Eisenacher, K., Mages, J., Haas, T., Krug, A., Janssen, K. P., Kirschning, C. J., Wagner, H. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 38, 2981-2992.
45. Hackstein, H., Taner, T., Zahorchak, A. F., Morelli, A. E., Logar, A. J., Gessner, A., Thomson, A. W. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101, 4457-4463.
46. Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z., Thomson, A. W. (2007) Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178, 7018-7031.
47. Hegde, V.l., Nagarkatti, P. S., Nagarkatti, M. (2011) Role of myeloidderived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 6, e18281.
48. Longhi, M. S., Mitry, R. R., Samyn, M., Scalori, A., Hussain, M. J., Quaglia, A., Mieli-Vergani, G., Ma, Y., Vergani, D. (2009) Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology 50, 130-142.
49. Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J., Sansom, O. J. (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122, 3127-3144.
50. Mei, J., Liu, Y., Dai, N., Hoffmann, C., Hudock, K. M., Zhang, P., Guttentag, S. H., Kolls, J. K., Oliver, P. M., Bushman, F. D., Worthen, G. S. (2012) Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J. Clin. Invest. 122, 974-986.